Company: LNAI
Filing Date: 2025-02-28
Form Type: 8-K
Source: 0001731122-25-000312
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-28
Form: 8-K
Item: Item 3.02
Chunk 0
---
Item 3.02 Unregistered
Sales of Equity Securities.

The disclosure set forth above in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02. The offer
and sale of the Shares to be issued to the stockholders of Biosymetrics in connection with the Transaction at the Closing has not been
registered under the Securities Act in reliance on the exemption from registration requirements provided by Section 4(a)(2) of the Securities
Act. The Company has represented to Renovaro that the Biosymetrics stockholders are “accredited investors” as defined in
Rule 501(a) under the Securities Act. Pursuant to the terms of the Merger Agreement, any Biosymetrics stockholder who is not deemed an
accredited investor at Closing shall receive a cash payment equivalent in value to such Shares the stockholder would have otherwise been
entitled to receive from the Stockholder Representative.

Item 7.01 Regulation
FD Disclosure.